4AB:FRA
AbbVie Common Stock
€229.50
arrow_downward
-0.78%(-1.80) 1D
Sep 22, 8:05:05 AM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4AB...
Open
€229.50
High
€229.50
Low
€229.50
Mkt. cap
467.37B
Avg. vol.
54.00
Volume
0.00
52-wk high
€234.40
52-wk low
€167.55
No. of employees
57K
Open
€229.50
High
€229.50
Low
€229.50
Mkt. cap
467.37B
Avg. vol.
54.00
Volume
0.00
52-wk high
€234.40
52-wk low
€167.55
No. of employees
57K
News stories
From web sources and news partners
Yahoo Finance
·
1 hour ago
AbbVie vs. Pfizer: Which Dividend Stock Is the Better Buy in September?
AD HOC NEWS
·
1 hour ago
AbbVie stock gains as RINVOQ wins European approval
Investing.com
·
3 hours ago
AbbVie’s Rinvoq gains EU approval for juvenile arthritis
TradingView
·
8 hours ago
Reflecting On Therapeutics Stocks’ Q2 Earnings: AbbVie (NYSE:ABBV)
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57K
FoundedApr 10, 2012
HeadquartersNorth Chicago, Illinois, United States
SectorBiotechnology
Websiteabbvie.com